Integral Derivatives’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,918
Closed -$404K 1009
2016
Q2
$404K Sell
2,918
-15,400
-84% -$2M 0.01% 658
2016
Q1
$2.31M Buy
18,318
+6,850
+60% +$871K 0.08% 188
2015
Q4
$1.45M Buy
11,468
+8,000
+231% +$993K 0.04% 351
2015
Q3
$401K Buy
3,468
+700
+25% +$78.6K 0.01% 773
2015
Q2
$288K Sell
2,768
-1,500
-35% -$162K 0.01% 886
2015
Q1
$471K Buy
4,268
+1,900
+80% +$206K 0.01% 714
2014
Q4
$247K Buy
+2,368
New +$237K ﹤0.01% 1156

Other funds holding CLX

Integral Derivatives's CLX Position: Q3 2016 in Review

Integral Derivatives sold out of Clorox (CLX) in Q3 2016, closing a stake of 2,918 shares — an estimated $404K sold.

Integral Derivatives first reported a position in CLX in Q4 2014 and held it in 7 quarters. The position peaked at $2.31M in Q1 2016. 823 funds tracked by Wall St. Rank hold CLX as of Q3 2016.

  • Integral Derivatives reported no remaining Clorox position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 2,918 Clorox shares in Q3 2016, an estimated $404K.
  • Integral Derivatives first reported a position in Clorox in Q4 2014 and held it in 7 quarters.
  • Integral Derivatives's Clorox position peaked at $2.31M in Q1 2016.
  • 823 funds tracked by Wall St. Rank held Clorox as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.